PM 8: Promising practices
developed to support the
continued planning,
development, and system for special pathogen patient care
|
What promising practices
have you developed to
help achieve the continued
planning, development, national system for special pathogen patient care using
RESPTC FY21 Administrative Supplement funds? What impact did you achieve? (Free response – 750-character response length)
|
RESPTC
|
Qualitative description of
promising impact achieved
|
PM 9: Challenges encountered by RESPTCs in the continued planning, development, and implementation of a national system for special pathogen patient care
|
What specific challenges have you encountered regarding your ability to plan, develop, and implement a national system for special pathogen care across sites? (Select all that apply)
-
Coordinating and communicating across facilities and partners (free response – 300-character response length)
-
Incentivizing participation from key stakeholders (free response – 300-character response length)
-
Aligning regional workplans with national NETEC initiatives (free response – 300-character response length)
-
Other (free response – 600-character response length)
Please briefly describe the impact of these challenges (free response – 600-character response length) |
RESPTC
|
Number of RESPTCs reporting each challenge
Qualitative description of challenges and impact of challenges
|
PM 10: Promising practices implemented by RESPTCs to access and use information and resources from NETEC
|
Which of the following promising practices did your RESPTC employ to access and use NETEC information and resources using
RESPTC FY21AdministrativeSupplement funds? (Select all that apply)
-
Utilized NETEC resources to improve operations and clinical outcomes within my RESPTC
-
Shared NETEC resources with other health care facilities, organizations, and staff
-
Participated in the provision of technical assistance by NETEC Subject Matter Experts (SMEs) for facilities in my region
-
Utilized the NETEC infrastructure to support capacity and capability to participate in emergency clinical research[5]
-
Other (free response – 750-character response length)
|
RESPTC
|
Number of RESPTCs
implementing each listed
promising practice
|
PM 11: Promising practices used that promote coordination and collaboration between RESPTCs and other regional disaster response organizations[6]
|
What promising practices did your organization use to collaborate with other regional organizations for disaster response (e.g., Regional Disaster Health Response System demonstration sites, Health Care Coalitions, etc.) using
RESPTC FY21 Administrative Supplement R funds? What impact did you achieve? (Free response – 750-character response length)
|
RESPTC |
Qualitative description of promising practices, partners, and impact achieved
|
PM 12: Promising practices associated with RESPTC initiatives to support the region’s special pathogen system of care
|
What promising practices did your organization use to support the region’s special pathogen system of care using
RESPTC FY21 AdministrativeSupplement funds? What impact did you achieve? (Free response – 750-character response length)
|
RESPTC |
Number of RESPTCs implementing initiatives Qualitative description of initiatives and impact achieved
|
PM 13: Challenges encountered during implementation of RESPTC initiatives that support the region’s special pathogen system of care
|
What specific challenges have you encountered regarding implementation of regional treatment center initiatives to support your region’s special pathogen system of care using
RESPTCFY21 AdministrativeSupplement funds? What were the impacts of these challenges? (Free response – 750-character response length)
|
RESPTC
|
Number of RESPTCs reporting challenges
Qualitative description of challenges and impact of challenges
|